@prefix dc1: . @prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix nt: . @prefix xsd: . @prefix rdfs: . @prefix orcid: . @prefix bl: . @prefix nkg: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { bl:category bl:Disease . sub:association rdf:object ; rdf:predicate bl:treats; rdf:subject ; a rdf:Statement; rdfs:label "dorzolamide hydrochloride ophthalmic solution 2 is indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma dorzolamide hydrochloride ophthalmic solution 2 is a carbonic anhydrase inhibitor indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open angle glaucoma 1"; bl:association_type bl:ChemicalToDiseaseOrPhenotypicFeatureAssociation; bl:provided_by ; bl:relation nkg:SymptomaticReliefIndication . bl:category bl:Drug . } sub:provenance { sub:assertion prov:wasAttributedTo orcid:0000-0002-1468-3557 . } sub:pubinfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"; npx:hasSignature "SJ+gumIZ77w5dSDqRXr7ZYGT8TtAei3oX6E0MrzA9IK0Ulf8YzOpQE71Y6YPkZr6H0sM13DnAabOw6KIFYliIodpWh6eVePgMoIMm2YLl0weBjGNBWFjAC5cAXiksp6KR7KruZdHdP77vtGFw/GlveXyjfhHExInuoYhHAEa1fE="; npx:hasSignatureTarget this: . this: dc1:created "2021-06-13T12:17:07.913+02:00"^^xsd:dateTime; dc1:creator orcid:0000-0002-1468-3557; nt:wasCreatedFromProvenanceTemplate ; nt:wasCreatedFromPubinfoTemplate ; nt:wasCreatedFromTemplate . }